Centene (NYSE:CNC) Stock Acquired Rep. Tim Moore

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation (NYSE:CNC). In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 30th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Verizon Communications (NYSE:VZ) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/18/2025.

Centene Stock Down 2.7%

Centene stock opened at $25.20 on Thursday. Centene Corporation has a fifty-two week low of $25.11 and a fifty-two week high of $80.59. The firm has a market capitalization of $12.37 billion, a PE ratio of 6.24, a P/E/G ratio of 1.06 and a beta of 0.40. The company’s 50-day moving average is $42.15 and its 200-day moving average is $54.03. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10.

Centene (NYSE:CNC) last posted its earnings results on Friday, July 25th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.39). Centene had a return on equity of 9.57% and a net margin of 1.15%. The business had revenue of $48.74 billion for the quarter, compared to analyst estimates of $44.71 billion. During the same period in the previous year, the firm posted $2.42 earnings per share. The firm’s revenue was up 22.4% compared to the same quarter last year. Sell-side analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CNC shares. UBS Group cut their price objective on shares of Centene from $45.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 28th. Barclays reduced their price target on Centene from $65.00 to $45.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 2nd. Bank of America cut Centene from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $52.00 to $30.00 in a research report on Wednesday, July 16th. Morgan Stanley reduced their target price on shares of Centene from $33.00 to $28.00 and set an “equal weight” rating for the company in a research report on Monday. Finally, Robert W. Baird lowered their price target on shares of Centene from $68.00 to $28.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $42.20.

Institutional Investors Weigh In On Centene

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Pinney & Scofield Inc. acquired a new stake in Centene in the fourth quarter valued at approximately $25,000. Ameriflex Group Inc. bought a new position in shares of Centene in the 4th quarter valued at $26,000. Quarry LP acquired a new stake in shares of Centene during the 1st quarter valued at $26,000. Studio Investment Management LLC bought a new stake in Centene during the 4th quarter worth $32,000. Finally, Golden State Wealth Management LLC increased its holdings in Centene by 203.1% in the 1st quarter. Golden State Wealth Management LLC now owns 579 shares of the company’s stock worth $35,000 after purchasing an additional 388 shares in the last quarter. 93.63% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director Theodore R. Samuels II purchased 9,000 shares of Centene stock in a transaction dated Monday, July 28th. The shares were bought at an average cost of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the acquisition, the director owned 32,000 shares in the company, valued at approximately $883,840. This trade represents a 39.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.36% of the company’s stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.